Changzhou Pharmaceutical Factory ( China (Mainland))

Changzhou Pharmaceutical Factory (CPF), established in the year of 1949 in Changzhou Jiangsu province, is a leading pharmaceutical manufacturer of API's , finished formulations in China. It is reformed as company limited from state-owned enterprise in 2001.  The factory has been awarded as State Class II Enterprise and High Technology Enterprise by the government. It covers an area of 110,000m² and employs 1000 staffs, including more than 300 technicians with different specialties. Specialized in producing cardiovascular pharmaceuticals and medicines, every year the output of 30 kind of API's is more than 3000 tons and that of 120 kind of finished formulations is more than 8,000 million tablets. The products are exported to over 50 countries.

The factory has been approved by Chinese GMP for finished dosages in 2002 and for APIs in 2004. Hydrochlorothiazide and Doxycycline Hyclate has been approved by U.S.FDA. The factory carries out management and production as per GMP requirements. It imported production equipments and test instruments from America, Europe, Japan etc. and passed FDA's latest inspection for the facility of Hydrochlorothiazide (58-93-5) and Doxycycline Hyclate (24390-14-5).